Ameer completed his undergraduate degree in Biochemistry at Dalhousie, and gained early exposure to research through the Co-op program. He worked with Dr. Paul Bentzen on conservation genetics of fish, and with Dr. Pollen Yeung, studying the pharmacokinetics of the anti-cancer drug Cladribine in mice. He conducted his Honours project in the Singer/Jonhston lab, where yeast is used as a model organism to study various cellular functions. The focus of his project was the characterization of mutant forms of the highly-conserved transcription factor FACT. Ameer stayed in the Singer/Johnston lab for his Master’s degree in Biochemistry, in which he took a high-throughput genetic approach in yeast to study a defect in the process of vesicular transport that is found in Alzheimer’s disease.
Ameer was involved in the HACE-1 tumor suppressor project and IGNITE, a Genome Canada-funded project that aims to characterize genes responsible for a number of orphan diseases, and use that knowledge to develop therapeutic interventions.